Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...

Bladder cancer ranks as the 10th most commonly diagnosed cancer globally, affecting both men and women. Approximately 75% of patients are initially diagnosed with non-muscle invasive bladder cancer ...

The Ottawa Hospital is at the forefront when it comes to cancer immunotherapy research — from new therapies to clinicals ...

Discover real-world data showing that only a minority of patients complete the recommended 4–6 chemotherapy cycles in bladder ...

Discover a study comparing two types of treatment for bladder cancer, robot-assisted radical cystectomy and intracorporeal ...

At ESMO 2024, Dr. Andrea Necchi presented the results of an interim analysis of SunRISe-4, noting a pathological complete response rate in the combination arm of 42% and pathologic objective response ...

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Every so often there is an urgent call for a national prostate cancer screening program to be introduced, usually following ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas was host to the Bladder Cancer Course and the session Metastatic Urothelial Cancer. Dr. Vadim S. Koshkin ...

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

As with other types of cancer, early detection and intervention is important and consulting with a veterinary oncologist is recommended so to better evaluate treatment options and prognosis. Dogs may ...

Key TakeawaysFirst-ever annual report from the American College of Surgeons National Cancer Database includes in-depth data ...